Pacific Biosciences of California Inc
F:P09

Watchlist Manager
Pacific Biosciences of California Inc Logo
Pacific Biosciences of California Inc
F:P09
Watchlist
Price: 22.77 EUR 2.34%
Market Cap: €1.7B

Wall St Price Targets

P09 Price Targets Summary
Pacific Biosciences of California Inc

Wall Street analysts forecast P09 stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for P09 is 2.44 EUR with a low forecast of 1.07 EUR and a high forecast of 3.35 EUR.

Lowest Forecast
Price Target
1.07 EUR
95% Downside
Average Forecast
Price Target
2.44 EUR
89% Downside
Highest Forecast
Price Target
3.35 EUR
85% Downside
Pacific Biosciences of California Inc Competitors:
Price Targets
TMO
Thermo Fisher Scientific Inc
37% Upside
WEED
Canopy Growth Corp
57% Upside
BARK
Bark Inc
322% Upside
MRKR
Marker Therapeutics Inc
450% Upside
DREAMFOLKS
Dreamfolks Services Ltd
79% Upside

Revenue
Forecast

12% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
12% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 7 years is 22%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-62%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-62%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is P09's stock price target?
Price Target
2.44 EUR

According to Wall Street analysts, the average 1-year price target for P09 is 2.44 EUR with a low forecast of 1.07 EUR and a high forecast of 3.35 EUR.

What is the Revenue forecast for Pacific Biosciences of California Inc?
Projected CAGR
22%

Over the last 14 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 7 years is 22%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett